Advertisement
News
Subscribe to Surgical Products Magazine News
View Sample

FREE Email Newsletter

Surgical Products Daily

Surgical Adhesive Receives Approval For First Module Of Its PMA

October 31, 2012 6:11 am | Comments

/PRNewswire/ -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, has announced that it has received approval from the United States Food and Drug Administration ("FDA") for the first of four modules of the Company's PMA filing plan for its TissuGlu®  Surgical Adhesive product.

TOPICS:

Sandy Prompts Harrowing NYC Hospital Evacuation

October 31, 2012 6:06 am | Comments

Rescuers and staff at New York University Langone Medical Center, some making 10 to 15 trips down darkened stairwells, began their mission Monday night, the youngest and sickest first, finishing about 15 hours later. Among the first out were 20 babies in neonatal intensive care, some on battery-powered respirators.

Man With Bionic Leg To Climb Chicago Skyscraper

October 31, 2012 6:03 am | Comments

CHICAGO (AP) — Zac Vawter considers himself a test pilot. After losing his right leg in a motorcycle accident, the 31-year-old software engineer signed up to become a research subject, helping to test a trailblazing prosthetic leg that's controlled by his thoughts. He will put this groundbreaking bionic leg to the ultimate test Sunday when he attempts to climb 103 flights of stairs to the top of Chicago's Willis Tower, one of the world's tallest skyscrapers.

Advertisement

Delayed Radiation Therapy After Hysterectomy Ups Cancer Recurrence Risk

October 31, 2012 5:59 am | Comments

DETROIT - Waiting too long after a hysterectomy to begin radiation therapy may increase the risk of uterine cancer recurrence, according to a new study from researchers at Henry Ford Hospital in Detroit. The study shows that for patients with uterine cancer not receiving chemotherapy, tumors were more likely to return if radiation therapy was delayed nine weeks or longer following surgery, with only 43 percent having relapse-free survival after five years.

FDA Approves Clinical Trial Of EndoBarrier

October 30, 2012 6:32 am | Comments

(BUSINESS WIRE)-- GI Dynamics, Inc.   has announced that it has received full approval from the U.S. Food and Drug Administration (  FDA  ) to commence a 25-site pivotal clinical trial of  EndoBarrier ® for the treatment of patients who have uncontrolled type 2 diabetes and are obese.

TOPICS:

Mammograms: For 1 Life Saved, 3 Women Overtreated

October 30, 2012 6:27 am | Comments

LONDON (AP) — Breast cancer screening for women over 50 saves lives, an independent panel in Britain has concluded, confirming findings in U.S. and other studies. But that screening comes with a cost: The review found that for every life saved, roughly three other women were overdiagnosed, meaning they were unnecessarily treated for a cancer that would never have threatened their lives.

Smoke-free Laws Led Quickly To Fewer Hospitalizations

October 30, 2012 6:22 am | Comments

Smoke-free legislation was associated with substantially fewer hospitalizations and deaths from heart and respiratory diseases, according to research in the American Heart Association journal  Circulation . Researchers reviewed 45 studies covering 33 smoke-free laws at the local and state levels around the United States and from countries as varied as Uruguay, New Zealand and Germany and found: Comprehensive smoke-free laws were associated with a rapid 15 percent decrease in heart attack hospitalizations and 16 percent decrease in stroke hospitalizations.

Obese Moms Give Birth To Heart Healthier Kids Following Bariatric Surgery

October 30, 2012 6:21 am | Comments

Kids born to moms who have lost a substantial amount of weight after undergoing bariatric surgery have fewer cardiovascular risk factors than their siblings who were born before the weight loss surgery. This is because the metabolic changes and weight loss that occur after the surgery have a positive effect on inflammatory disease-related genes in the offspring, according to a new study presented at the Canadian Cardiovascular Congress, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Advertisement

Routine Electrocardiograms Predict Health Risks For Patients With Atrial Fibrillation

October 29, 2012 6:09 am | Comments

Canadian scientists have determined that routine electrocardiogram (ECG) results for patients with atrial fibrillation (AF) — the most common form of irregular heart beat — can help doctors identify those at higher risk of adverse cardiovascular outcomes, including death. This knowledge will help doctors improve the treatment and prognosis of atrial fibrillation.

Minorities Most Likely To Have Aggressive Tumors, Less Likely To Get Radiation

October 29, 2012 6:05 am | Comments

SAN DIEGO — Women with aggressive breast cancer were more likely to receive adjuvant chemotherapy, but at the expense of completing locoregional radiation therapy, according to recently presented data. This was especially true in minorities, who were the most likely to present with moderate- to high-grade and symptomatically detected tumors.

A Comprehensive Solution for Non-Invasive Surgical Procedures Unveiled

October 29, 2012 5:46 am | Comments

/PRNewswire/ -- ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) today unveiled its next move against cancer, the new EDGE™ Radiosurgery Suite* -- a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities.

FDA Clearance And CE Mark Approval For Intra-Aortic Balloon Catheter Received

October 29, 2012 5:40 am | Comments

/PRNewswire/ -- MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS® 7.5Fr. 40cc intra-aortic balloon (IAB) catheter.

Anesthesia Drugs Really Do Put Patients To Sleep

October 26, 2012 6:33 am | Comments

When patients are put under anesthesia, they are often told they will be "put to sleep," and now it appears that in some ways that's exactly what the drugs do to the brain. New evidence in mice reported online on October 25 in  Current Biology , a Cell Press publication, shows that the drugs don't just turn wakefulness "off," they also force important sleep circuits in the brain "on.

Reaction To RESPECT Trial Results

October 26, 2012 6:18 am | Comments

(BUSINESS WIRE)-- W. L. Gore & Associates (Gore)  today responded to initial results reported in St. Jude Medical, Inc.’s RESPECT clinical trial. The RESPECT study investigated whether transcatheter closure of PFO using St Jude’s AMPLATZER® PFO Occluder device is safe and effective compared to best medical therapy in the prevention of recurrent cryptogenic stroke.

Stroke Survivors Who Smoke Raise Risk Of More Problems

October 26, 2012 6:12 am | Comments

Stroke survivors who smoke put themselves at a greater risk of additional strokes, heart attack or death than those who never smoked, according to new research in the American Heart Association's journal  Stroke . Those who quit smoking before their stroke also had less risk of poorer outcomes than current smokers, researchers found.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading